{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:58:41Z","timestamp":1783612721564,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82174135"],"award-info":[{"award-number":["82174135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project of Famous Traditional Chinese Medicine Studio in Pudong New Area","award":["PDZY-2025-0702"],"award-info":[{"award-number":["PDZY-2025-0702"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-025-01104-2","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:34:35Z","timestamp":1763631275000},"page":"1741-1756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Tumor-homing nanoplatform for the co-delivery of triptolide and siRNA-A4B2 conspicuously overcomes peritoneum metastasis of ovarian cancer"],"prefix":"10.1007","volume":"48","author":[{"given":"Chenhuan","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"2","key":"1104_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","volume":"19","author":"DK Armstrong","year":"2021","unstructured":"D.K. Armstrong, et al., Ovarian Cancer, Version 2.2020, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc Netw. 19(2), 191\u2013226 (2021)","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"1","key":"1104_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1200\/JCO.23.02005","volume":"42","author":"F Meric-Bernstam","year":"2024","unstructured":"F. Meric-Bernstam et al., Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: primary results from the DESTINY-PanTumor02 phase II trial. J. Clin. Oncol. 42(1), 47\u201358 (2024)","journal-title":"J. Clin. Oncol."},{"key":"1104_CR3","doi-asserted-by":"crossref","unstructured":"O. Elyashiv et al., The poor prognosis of acquired secondary platinum resistance in ovarian cancer patients. Cancers (Basel), 2024. 16(3)","DOI":"10.3390\/cancers16030641"},{"issue":"3","key":"1104_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"E. Lengyel, Ovarian cancer development and metastasis. Am. J. Pathol. 177(3), 1053\u20131064 (2010)","journal-title":"Am. J. Pathol."},{"issue":"7578","key":"1104_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"A. Hoshino et al., Tumour exosome integrins determine organotropic metastasis. Nature. 527(7578), 329\u2013335 (2015)","journal-title":"Nature"},{"key":"1104_CR6","doi-asserted-by":"publisher","first-page":"108458","DOI":"10.1016\/j.pharmthera.2023.108458","volume":"247","author":"F Liu","year":"2023","unstructured":"F. Liu et al., Integrins in cancer: Emerging mechanisms and therapeutic opportunities. Pharmacol. Ther. 247, 108458 (2023)","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"1104_CR7","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41390-020-01177-9","volume":"89","author":"OJ Mezu-Ndubuisi","year":"2021","unstructured":"O.J. Mezu-Ndubuisi, A. Maheshwari, The role of integrins in inflammation and angiogenesis. Pediatr. Res. 89(7), 1619\u20131626 (2021)","journal-title":"Pediatr. Res."},{"issue":"5","key":"1104_CR8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.2174\/1871520618666181119103413","volume":"19","author":"I \u0141asi\u00f1ska","year":"2019","unstructured":"I. \u0141asi\u00f1ska, J. Mackiewicz, Integrins as a new target for cancer treatment. Anticancer Agents Med. Chem. 19(5), 580\u2013586 (2019)","journal-title":"Anticancer Agents Med. Chem."},{"issue":"1","key":"1104_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13045-021-01192-1","volume":"14","author":"J Xiong","year":"2021","unstructured":"J. Xiong et al., Integrins regulate stemness in solid tumor: an emerging therapeutic target. J. Hematol. Oncol. 14(1), 177 (2021)","journal-title":"J. Hematol. Oncol."},{"key":"1104_CR10","doi-asserted-by":"publisher","first-page":"1121964","DOI":"10.3389\/fmolb.2023.1121964","volume":"10","author":"SU Khan","year":"2023","unstructured":"S.U. Khan et al., Role of LGMN in tumor development and its progression and connection with the tumor microenvironment. Front. Mol. Biosci. 10, 1121964 (2023)","journal-title":"Front. Mol. Biosci."},{"issue":"9","key":"1104_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1161\/CIRCULATIONAHA.121.056640","volume":"145","author":"L Pan","year":"2022","unstructured":"L. Pan et al., Legumain is an endogenous modulator of integrin alphavbeta3 triggering vascular degeneration, dissection, and rupture. Circulation. 145(9), 659\u2013674 (2022)","journal-title":"Circulation"},{"issue":"11","key":"1104_CR12","doi-asserted-by":"publisher","first-page":"101293","DOI":"10.1016\/j.xcrm.2023.101293","volume":"4","author":"J Mitchell","year":"2023","unstructured":"J. Mitchell et al., The missing link? LGMN connects hypoxia and immunosuppression in glioblastoma. Cell. Rep. Med. 4(11), 101293 (2023)","journal-title":"Cell. Rep. Med."},{"issue":"1","key":"1104_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.7150\/ijbs.36467","volume":"16","author":"H Wang","year":"2020","unstructured":"H. Wang et al., Legumain promotes gastric cancer progression through tumor-associated macrophages in vitro and in vivo. Int. J. Biol. Sci. 16(1), 172\u2013180 (2020)","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"1104_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/humrep\/deab266","volume":"37","author":"SG Sun","year":"2022","unstructured":"S.G. Sun et al., The extracellular vesicular pseudogene LGMNP1 induces M2-like macrophage polarization by upregulating LGMN and serves as a novel promising predictive biomarker for ovarian endometriosis recurrence. Hum. Reprod. 37(3), 447\u2013465 (2022)","journal-title":"Hum. Reprod."},{"key":"1104_CR15","doi-asserted-by":"publisher","first-page":"109221","DOI":"10.1016\/j.exer.2022.109221","volume":"224","author":"Q Tang","year":"2022","unstructured":"Q. Tang et al., Legumain affects the PI3K\/AKT tumor progression pathway in retinoblastoma. Exp. Eye Res. 224, 109221 (2022)","journal-title":"Exp. Eye Res."},{"issue":"31","key":"1104_CR16","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.2174\/1381612826666201125111625","volume":"27","author":"BD Reddy","year":"2021","unstructured":"B.D. Reddy et al., An overview of targeting legumain for inhibiting cancers. Curr. Pharm. Des. 27(31), 3337\u20133348 (2021)","journal-title":"Curr. Pharm. Des."},{"issue":"34","key":"1104_CR17","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1038\/s41388-022-02409-4","volume":"41","author":"C Liu","year":"2022","unstructured":"C. Liu et al., Autocrine pro-legumain promotes breast cancer metastasis via binding to integrin alphavbeta3. Oncogene. 41(34), 4091\u20134103 (2022)","journal-title":"Oncogene"},{"key":"1104_CR18","doi-asserted-by":"crossref","unstructured":"R.N. Hamzah et al., Exosome traceability and cell source dependence on composition and cell-cell cross talk. Int. J. Mol. Sci., 22(10) 2021.","DOI":"10.3390\/ijms22105346"},{"issue":"16","key":"1104_CR19","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","volume":"68","author":"B Gyorgy","year":"2011","unstructured":"B. Gyorgy et al., Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell. Mol. Life Sci. 68(16), 2667\u20132688 (2011)","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"1104_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41556-018-0040-4","volume":"20","author":"H Zhang","year":"2018","unstructured":"H. Zhang et al., Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell. Biol. 20(3), 332\u2013343 (2018)","journal-title":"Nat. Cell. Biol."},{"issue":"3","key":"1104_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/pr.112.005983","volume":"64","author":"E van der Pol","year":"2012","unstructured":"van der E. Pol et al., Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 64(3), 676\u2013705 (2012)","journal-title":"Pharmacol. Rev."},{"key":"1104_CR22","doi-asserted-by":"crossref","unstructured":"R. Crescitelli et al., Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J. Extracell. Vesicles 2 2013.","DOI":"10.3402\/jev.v2i0.20677"},{"key":"1104_CR23","doi-asserted-by":"crossref","unstructured":"A. Rajput et al., Exosomes as new generation vehicles for drug delivery: biomedical applications and future perspectives. Molecules, 2022. 27(21)","DOI":"10.3390\/molecules27217289"},{"key":"1104_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/HM9.0000000000000039","volume":"2","author":"Z Zhu","year":"2022","unstructured":"Z. Zhu, L. Liao, H. Qiao, Extracellular vesicle\u2013based drug delivery system boosts phytochemicals\u2019 therapeutic effect for neurodegenerative diseases. Acupunct. Herb. Med. 2, 229\u2013239 (2022)","journal-title":"Acupunct. Herb. Med."},{"issue":"10","key":"1104_CR25","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1172\/JCI129193","volume":"129","author":"S Kita","year":"2019","unstructured":"S. Kita, N. Maeda, I. Shimomura, Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome. J. Clin. Invest. 129(10), 4041\u20134049 (2019)","journal-title":"J. Clin. Invest."},{"issue":"1","key":"1104_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12885-017-3958-1","volume":"18","author":"S Horibe","year":"2018","unstructured":"S. Horibe et al., Mechanism of recipient cell-dependent differences in exosome uptake. BMC Cancer. 18(1), 47 (2018)","journal-title":"BMC Cancer"},{"key":"1104_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-animal-020518-115300","volume":"7","author":"J Zempleni","year":"2019","unstructured":"J. Zempleni et al., Milk-derived exosomes and metabolic regulation. Annu. Rev. Anim. Biosci. 7, 245\u2013262 (2019)","journal-title":"Annu. Rev. Anim. Biosci."},{"issue":"24","key":"1104_CR28","doi-asserted-by":"publisher","first-page":"17713","DOI":"10.1074\/jbc.M112.445403","volume":"288","author":"KJ Svensson","year":"2013","unstructured":"K.J. Svensson et al., Exosome uptake depends on ERK1\/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J. Biol. Chem. 288(24), 17713\u201317724 (2013)","journal-title":"J. Biol. Chem."},{"issue":"1","key":"1104_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12964-020-00581-2","volume":"18","author":"W Wang","year":"2020","unstructured":"W. Wang et al., The crosstalk: exosomes and lipid metabolism. Cell. Commun. Signal. 18(1), 119 (2020)","journal-title":"Cell. Commun. Signal."},{"issue":"1","key":"1104_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13071-023-05694-4","volume":"16","author":"Y Chu","year":"2023","unstructured":"Y. Chu et al., Clonorchis sinensis legumain promotes migration and invasion of cholangiocarcinoma cells via regulating tumor-related molecules. Parasit. Vectors. 16(1), 71 (2023)","journal-title":"Parasit. Vectors"},{"key":"1104_CR31","doi-asserted-by":"crossref","unstructured":"Y.J. Wang et al., Structure characterization of fur new sesquiterpene pyridine alkaloids fom tripterygium wilfordii hook. F. and anti-inflammatory activity evaluations. Molecules, 2024. 29(22)","DOI":"10.3390\/molecules29225284"},{"issue":"1","key":"1104_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12935-024-03336-y","volume":"24","author":"S Bao","year":"2024","unstructured":"S. Bao et al., Antitumor mechanisms and future clinical applications of the natural product triptolide. Cancer Cell. Int. 24(1), 150 (2024)","journal-title":"Cancer Cell. Int."},{"key":"1104_CR33","doi-asserted-by":"publisher","first-page":"12975","DOI":"10.2147\/IJN.S498099","volume":"19","author":"L Zhou","year":"2024","unstructured":"L. Zhou et al., A novel triptolide Nano-Liposome with mitochondrial targeting for treatment of hepatocellular carcinoma. Int. J. Nanomed. 19, 12975\u201312998 (2024)","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"1104_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/HM9.0000000000000131","volume":"4","author":"F Chen","year":"2024","unstructured":"F. Chen et al., Considerations regarding the application of Chinese herbal medicine-derived extracellular vesicle-like particles in a drug delivery system. Acupunct. Herb. Med. 4(4), 423\u2013426 (2024)","journal-title":"Acupunct. Herb. Med."},{"key":"1104_CR35","doi-asserted-by":"crossref","unstructured":"W. Feng et al., Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol. Cancer 18(1), 124 (2019)","DOI":"10.1186\/s12943-019-1049-4"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01104-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01104-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01104-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:57:12Z","timestamp":1765443432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01104-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01104-2","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by the Animal Care and Use Committee of the Shanghai Cancer Institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and agreed to submit the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}